Medications known as GLP-1 receptor agonists, widely used to manage Type 2 diabetes and support weight loss, are now being linked to a modest increase in the risk of erectile dysfunction (ED), according to a recent 2026 study using a target trial emulation design published in the Journal eClinicalMedicine
Zhao T, Yu LH, Zhang HL, Yu J, Feng J, Wang TT, et al
The article uses the contrast between rows to argue that individual health status matters more than chronological age on its own
Nutrition research reviews, 21(2), pp.11733
Across both programs, researchers tracked adverse events meticulously, documenting everything from nausea to injection site reactions
The criteria stipulate that one must exhibit signs of increased pressure in the skull without any specific neurological signs, have no deformity or obstruction in the ventricles of the brain, and be fully conscious